64.7% of Respondents Reported Eventually Quitting GLP-1s 64.7% of participants in our study reported eventually quitting the use of GLP-1 medications
A body composition scale that tracks muscle mass and body fat percentage gives you much better data for tracking progress beyond just the number on the scale
Our providers listen first, then help you find a path that works, whether thats injectable GLP-1s now or oral options as they become available through our programs
However, the philosophy behind carnivore eating is different
In trials, participants without diabetes who took oral semaglutide daily for 68 weeks lost an average of 15% of their body weight, comparable to the results seen with injectable forms of semaglutide
An investigator may temporarily interrupt study intervention, for example, in the event of acute illness, surgery, or hospitalization